Edwards Enters Embolic Filtration Market With Embol-X Technology
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will offer embolic filtration technology developed by Embol-X, Inc. for use during open-heart procedures such as valve replacement under an asset purchase valued at about $10 mil